Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone

International Journal of Impotence Research volume 18, pages 400–404 (2006)Cite this article

Abstract

To investigate the therapeutic effect of androgen on hypogonadal patients unresponsive to sildenafil alone. In total, 32 hypogonadal patients with erectile dysfunction (ED), initially had an inadequate response to sildenafil (100 mg). Oral testosterone undecanoate (Restandol®, 80 mg, bid or tid) alone was supplied for 2 months, and if patients could not achieve a satisfactory erection, combined use of testosterone and sildenafil was continued thereafter. Total testosterone (TT), free testosterone (FT), and the parameters of the International Index of Erectile Function (IIEF), International Prostate Symptom Score (IPSS), and uroflow rate (UFR) were assessed. Eleven patients (34.3%) achieved satisfactory erectile function after testosterone replacement only. Another 12 (37.5%) patients experienced satisfactory intercourse after combined therapy. Serum TT and FT levels significantly increased after the use of testosterone alone (415±163 vs 220±101 ng/dl, P<0.01; 10.4±4.6 vs 5.1±1.9 ng/dl; P<0.01, respectively) and the combined use of testosterone and sildenafil (498±178 vs 220±101 ng/dl, P<0.01; 11.7±4.6 vs 5.1±1.9 ng/dl, P<0.001, respectively); as did the IIEF score (14.8±6.8 vs 12.6±7.5, P<0.01, 17.5±5.2 vs 12.6±7.5, P<0.001, respectively). However, no statistical differences were demonstrated for IPSS or UFR. In conclusions, one-third of hypogonadal patients with ED who failed to respond to sildenafil, responded to testosterone alone, another third responded to sildenafil again after normalization of testosterone. So, in hypogonadal patients with ED, androgen supplementation is first-line therapy. If patients are unresponsive to androgen alone or sildenafil alone, combined use may improve erectile function and enhance the therapeutic effect of PDE-5 inhibitors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA . Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397–1404.

    Article  CAS  PubMed  Google Scholar 

  2. Nickel JC, Morales A, Condra M, Fenemore J, Surridge DH . Endocrine dysfunction in impotence: incidence, significance and cost-effective screening. J Urol 1984; 132: 40–43.

    Article  CAS  PubMed  Google Scholar 

  3. Aversa A, Isidori AM, De Martino MU, Caprio M, Fabbrini E, Rocchietti-March M et al. Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocrinol 2000; 53: 517–522.

    Article  CAS  Google Scholar 

  4. Park K, Kim SW, Kim KD, Paick JS . Effects of androgens on the expression of nitric oxide synthase mRNAs in rat corpus cavernosum. BJU Int 1999; 83: 327–333.

    Article  CAS  PubMed  Google Scholar 

  5. Ding AQ, Stallone JN . Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation. J Appl Physiol 2001; 91: 2742–2750.

    Article  CAS  PubMed  Google Scholar 

  6. Traish AM, Park K, Dhir V, Kim NN, Moreland RB, Goldstein I . Effects of castration and androgen replacement on erectile function in a rabbit mode. Endocrinology 1999; 140: 1861–1868.

    Article  CAS  PubMed  Google Scholar 

  7. Lin C, Chow S, Lau A, Tu R, Lue TF . Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: identification of a critical Sp-1 binding site. Biochem Biophys Res Comm 2001; 280: 693–699.

    Article  CAS  PubMed  Google Scholar 

  8. Vermeulen A . Androgen replacement therapy in the aging male – a critical evaluation. J Clin Endocrinol Metab 2001; 86: 2380–2387.

    CAS  PubMed  Google Scholar 

  9. Shabsigh R, Kaufman JM, SteidLe C, Padma-Nathan H . Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004; 172: 658–663.

    Article  CAS  PubMed  Google Scholar 

  10. Anderson RA, Bancroft J, Wu FC . The effects of exogenous testosterone on sexuality and mood of normal men. Clin Endocrinol Metab 1992; 75: 1503–1507.

    CAS  Google Scholar 

  11. Aversa A, Isidorit AM, Spera G, Lenzi A, Fabbri A . Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol 2003; 58: 632–638.

    Article  CAS  Google Scholar 

  12. Jockenhovel F . Testosterone therapy: what, when, and to whom. Aging Male 2004; 7: 319–324.

    Article  CAS  PubMed  Google Scholar 

  13. Guay AT, Bansal S, Heatley GJ . Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double-blind placebo-controlled trial with clomiphene citrate. J Clin Endocrinol Metab 1995; 80: 3546–3552.

    CAS  PubMed  Google Scholar 

  14. Foresta C, Caretta N, Rossato M, Garolla A, Ferlin A . Role of androgens in erection function. J Urol 2004; 171: 2358–2362.

    Article  CAS  PubMed  Google Scholar 

  15. Bhasin S, Bagatel CJ, Bremner WJ, Plymate SR, Tenover JL, Korenman SG et al. Issues in testosterone replacement in older men. J Clin Endocrinol Metab 1998; 83: 3435–3448.

    Article  CAS  PubMed  Google Scholar 

  16. Gooren LJ . Endocrine aspects of ageing in the male. Mol Cell Endocrinol 1998; 145: 153–159.

    Article  CAS  PubMed  Google Scholar 

  17. Lugg JA, Rajfer J, Gonzalez-Cadavid NF . Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat. Endocrinology 1995; 136: 1495–1501.

    Article  CAS  PubMed  Google Scholar 

  18. Rajasekaran M, Mondal D, Agrawal K, Chen I, Hellstrom W, Sikka S . Ex vivo expression of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile cavernosal cells. J Urol 1998; 160: 2210–2214.

    Article  CAS  PubMed  Google Scholar 

  19. Janini EA, Screponi E, Carosa E, Pepe M, Logiudice F, Trimarch F et al. Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone. Int J Androl 1999; 22: 385–392.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Dr Paul C Chang for reviewing of the manuscript.

Author information

Authors and Affiliations

  1. Division of Urology, Department of Surgery, Shin Kong WHS Memorial Hospital, Taipei, Taiwan

    Ti-S Hwang, H-E Chen, T-F Tsai & Y C Lin

  2. Department of Urology, Taipei Medical University, Taipei, Taiwan

    Ti-S Hwang

  3. Department of Urology, College of Medicine, Fu-Jen Catholic University, Taipei, Taiwan

    Ti-S Hwang

Authors
  1. Ti-S Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H-E Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T-F Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y C Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ti-S Hwang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hwang, TS., Chen, HE., Tsai, TF. et al. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone. Int J Impot Res 18, 400–404 (2006). https://doi.org/10.1038/sj.ijir.3901446

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901446

Keywords

This article is cited by

Search

Advanced search

Quick links